ReviewOncology and therapy2022

Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit.

Sophia Z Humphreys et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.